- Q1 2 %6,2
- Q2 17 %53,1
- Q3 11 %34,4
- Q4 2 %6,2
Akademisyen
NURAY GÜZELDEMİRCİ
PROFESÖR
İSTANBUL ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
Araştırma konuları OpenAlex
- Synthesis and biological activity26
- Synthesis and Characterization of Heterocyclic Compounds15
- Click Chemistry and Applications9
- Computational Drug Discovery Methods6
- Cholinesterase and Neurodegenerative Diseases5
- Enzyme function and inhibition4
- Free Radicals and Antioxidants4
- Natural Antidiabetic Agents Studies4
- Redox biology and oxidative stress2
- Synthesis and Biological Evaluation2
- Cell death mechanisms and regulation2
- Synthesis and Reactivity of Sulfur-Containing Compounds2
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
Akademik özet
YÖKSİS ve OpenAlex ayrı sayılır.
Makale
74
YÖKSİS74
OpenAlex0
Proje
73
Kitap
9
Bildiri
67
Atıf etkisi
OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 33
h-indeks
13
Türkiye yüzdelik dilimi: 92
Üniversitesinde h-indekse göre 261. / 2.120
- i10-indeks
- 18
- Toplam atıf
- 681 Türkiye’de üst %7,5
- Makale başına
- 20,6
- FWCI
- 2,19 1,00 = dünya ortalaması
- Dünyada üst %1
- 0
- Dünyada üst %10
- 10
En çok atıf alan makaleleri
- Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones
- Design and Synthesis of Novel Imidazo[2,1-b]thiazole Derivatives as Potent Antiviral and Antimycobacterial Agents
- Antioxidant activity of novel imidazo[2,1-b]thiazole derivatives: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction
h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.
Alan sıralaması
YÖKSİS ?-
Ana dal Sağlık Bilimleri Temel AlanıPuan sırası #5.829/ 43.834 üst %13,3 Üniversitede #218/ 776Puan 33,15 dergi 32,4 · OA ek 0,75
- Makale sırası4.243/43.834
- Scopus sırası7.141/43.834
- WoS sırası6.536/43.834
- YÖKSİS74
- Scopus32
- WoS33
-
Yan dal Farmasotik KimyaPuan sırası #40/ 242 üst %16,5 Üniversitede #2/ 11Puan 33,15 dergi 32,4 · OA ek 0,75
- Makale sırası31/242
- Scopus sırası42/242
- WoS sırası42/242
- YÖKSİS74
- Scopus32
- WoS33
Dizin çeyrekleri
?- Q1 3 %9,1
- Q2 12 %36,4
- Q3 10 %30,3
- Q4 8 %24,2
Üst %10
Üst %1010
Ort. · n 35
%72,1
Diğer sayımlar
Scopus (SJR)
- YÖKSİS satırı 34
WoS (JCR)
- YÖKSİS satırı 35
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Yayını olan dergiler
19 dergi
- Journal of Molecular Structure 9
- Journal of Research in Pharmacy 4
- Chemical Biology and Drug Design 3
- ChemistrySelect 3
- Turkish Journal of Pharmaceutical Sciences 3
- ISSN 2651-4060 2
- Bioorganic Chemistry 2
- ISSN 2147-0634 1
- ISSN 2149-7893 1
- ISSN 2548-0731 1
- ISSN 2587-2087 1
- Anti-Cancer Agents in Medicinal Chemistry 1
- Archiv der Pharmazie 1
- Bioorganic and Medicinal Chemistry 1
- IUCrData 1
- Journal of Heterocyclic Chemistry 1
- Medicinal Chemistry Research 1
- Phosphorus, Sulfur and Silicon and the Related Elements 1
- Scientific Reports 1
Daralt
Makale listesi
- 2025 New 4-methanesulfonyloxy benzohydrazide derivatives as potential antioxidant and carbonic anhydrase I and II inhibitors: synthesis, characterization, molecular docking, dynamics & ADME studies YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.4%
- 2025 Preliminary Investigations on Acyl Hydrazones Bearing Sulfonamides as Inhibitors of the Human Carbonic Anhydrase Isoforms I, II, IX, and XII YÖKSİS SJR Q3 JCR Q3 OpenAlex 50.3%
- 2025 Novel Imidazo[2,1‐b]thiazole Based 4‐Thiazolidinones: Molecular Dynamics Guided Design, Synthesis, and α‐Glucosidase Inhibitory Evaluation YÖKSİS SJR Q3 JCR Q3 OpenAlex 81.1%
- 2025 In silico and in vitro antibacterial evaluation of eight Anatolian Salvia species with chemical profiling by LC-HRMS YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.9%
- 2025 New Imidazo[2,1‐b]thiazole Linked Hydrazide–Hydrazones as Potent α‐Glucosidase Inhibitors: Synthesis, Biological Evaluation, and Docking Insights YÖKSİS SJR Q3 JCR Q3 OpenAlex 87.5%
- 2025 Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studies YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 98.2%
- 2025 Discovery of Dual‐Inhibitor Acyl Hydrazones for Acetylcholinesterase and Carbonic Anhydrase I/II: A Mechanistic Insight into Alzheimers Disease YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 92.7%
- 2025 Synthesis, Characterization, and Antimicrobial Evaluation of Some Novel Hydrazinecarbothioamides YÖKSİS TR Index SJR Q2 JCR Q4 OpenAlex 77.1%
- 2025 Synthesis and Cytotoxic Effects of Various Thiosemicarbazide Compounds on Primary and Metastatic Breast Cancer Cell Lines YÖKSİS TR Index JCR Q4 OpenAlex 56.2%
- 2025 Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors YÖKSİS TR Index JCR Q4 OpenAlex 81.6%
- 2024 Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimers disease YÖKSİS SJR Q2 JCR Q2
- 2024 A newly synthesized thiosemicarbazide derivative trigger apoptosis rather than necroptosis on HEPG2 cell line YÖKSİS SJR Q2 JCR Q2 OpenAlex 54.0%
- 2024 Novel hydrazide‐hydrazone containing 1,2,4‐triazole as potent inhibitors of antiapoptotic protein Bcl‐xL: Synthesis, biological evaluation, and docking studies YÖKSİS SJR Q2 JCR Q2 OpenAlex 65.8%
- 2024 Synthesis and in vitro carbonic anhydrase and acetylcholinesterase inhibitory activities of novel hydrazide-hydrazone compounds containing 1,2,4-triazole ring YÖKSİS SJR Q4 JCR Q3 OpenAlex 85.4%
- 2024 Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular modeling studies of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 33.5%
- 2023 Synthesis of Novel Carboxamide Derivatives: Insecticidal Activity, Acetylcholinesterase Activity and In Silico Calculations YÖKSİS SJR Q2 JCR Q2 OpenAlex 4.6%
- 2023 Design, synthesis and biological evaluation of novel tetralone/indanone containing thiosemicarbazone derivatives with selective COX-2 inhibition as anticancer agents YÖKSİS SJR Q2 JCR Q2 OpenAlex 62.4%
- 2023 Synthesis, characterization, molecular docking and in vitro anti-cancer activity studies of new and highly selective 1,2,3-triazole substituted 4-hydroxybenzohyrdazide derivatives YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 97.0%
- 2023 Recent Advances of Cholinesterase Inhibitors Playing A Critical Role In The Treatment of Alzheimer's Disease (2020-2022) YÖKSİS TR Index
- 2023 Novel 4-thiazolidinone derivatives bearing imidazo[2,1-b]thiazole moiety: Design, synthesis, and antiviral activity evaluation YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 53.4%